Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men

被引:24
作者
Takaeko, Yuji [1 ]
Matsui, Shogo [1 ]
Kajikawa, Masato [2 ]
Maruhashi, Tatsuya [1 ]
Kishimoto, Shinji [1 ]
Hashimoto, Haruki [1 ]
Kihara, Yasuki [1 ]
Hida, Eisuke [3 ]
Chayama, Kazuaki [4 ]
Goto, Chikara [5 ]
Aibara, Yoshiki [6 ]
Yusoff, Farina Mohamad [6 ]
Noma, Kensuke [2 ,6 ]
Nakashima, Ayumu [7 ]
Higashi, Yukihito [2 ,6 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Div Regenerat & Med, Med Ctr Translat & Clin Res, Hiroshima, Japan
[3] Osaka Univ, Grad Sch Med, Dept Biostat & Data Sci, Osaka, Japan
[4] Hiroshima Univ, Dept Gastroenterol & Metab, Inst Biomed & Hlth Sci, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan
[5] Hiroshima Int Univ, Dept Physiol Therapy, Hiroshima, Japan
[6] Hiroshima Univ, Dept Cardiovasc Regenerat & Med, Res Inst Radiat Biol & Med, Hiroshima, Japan
[7] Hiroshima Univ, Grad Sch Biomed Sci, Dept Stem Cell Biol & Med, Hiroshima, Japan
关键词
High-density lipoprotein cholesterol; Endothelial function; Flow-mediated vasodilation; Men; Atherosclerosis; CORONARY-HEART-DISEASE; FLOW-MEDIATED DILATION; TRANSFER PROTEIN GENE; CARDIOVASCULAR EVENTS; HDL CHOLESTEROL; RISK-FACTOR; VASODILATION; DEFICIENCY; MORTALITY; COMMUNITY;
D O I
10.1016/j.jacl.2019.06.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: It is not clear whether a high level of high-density lipoprotein cholesterol (HDL-C) is associated with lower risk of atherosclerosis. It is likely that HDL-C is a double-edged sword for atherosclerosis. OBJECTIVE: The purpose of this study was to evaluate the relationship between HDL-C levels and endothelial function in men. METHODS: This was a cross-sectional study. We evaluated flow-mediated vasodilation (FMD) and serum levels of HDL-C in 5842 men aged 18 to 92 years who were not receiving lipid-lowering therapy. All participants were divided into four groups by HDL-C level: low HDL-C (<40 mg/dL), moderate HDL-C (40-59 mg/dL), high HDL-C (60-79 md/dL), and extremely high HDL-C (>= 80 mg/dL). We were not able to evaluate the amount of alcohol intake because there was limited information on the amount of alcohol drinking in our database. RESULTS: FMD values were significantly smaller in the low group and the extremely high group than in the high group (P = .001 and P = .016, respectively). There was no significant difference in FMD between the low group and the extremely high group. Multiple logistic regression analysis revealed that extremely high HDL-C, but not low HDL-C, was independently associated with the lowest quartile of FMD (odds ratio: 1.39, 95% confidence interval: 1.09-1.77; P = .009). CONCLUSIONS: An extremely high level of HDL-C in men (8.1% of this population) was associated with a significant reduction in FMD. (C) 2019 National Lipid Association. Published by Elsevier Inc.
引用
收藏
页码:664 / 672
页数:9
相关论文
共 56 条
[21]   Disease-associated marked hyperalphalipoproteinemia [J].
Hirano, Ken-Ichi ;
Nagasaka, Hironori ;
Kobayashi, Kazuhiro ;
Yamaguchi, Satoshi ;
Suzuki, Akira ;
Toda, Tatsushi ;
Doyu, Manabu .
MOLECULAR GENETICS AND METABOLISM REPORTS, 2014, 1 :264-268
[22]   Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study [J].
Hirata, Aya ;
Sugiyama, Daisuke ;
Watanabe, Makoto ;
Tamakoshi, Akiko ;
Iso, Hiroyasu ;
Kotani, Kazuhiko ;
Kiyama, Masahiko ;
Yamada, Michiko ;
Ishikawa, Shizukiyo ;
Murakami, Yoshitaka ;
Miura, Katsuyuki ;
Ueshima, Hirotsugu ;
Okamura, Tomonori .
JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (03) :674-684
[23]   The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population [J].
Hirata, Aya ;
Okamura, Tomonori ;
Sugiyama, Daisuke ;
Kuwabara, Kazuyo ;
Kadota, Aya ;
Fujiyoshi, Akira ;
Miura, Katsuyuki ;
Okuda, Nagako ;
Ohkubo, Takayoshi ;
Okayama, Akira ;
Ueshima, Hirotsugu .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (07) :800-809
[24]   A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan [J].
Hirata, Takumi ;
Sugiyama, Daisuke ;
Nagasawa, Shin-ya ;
Murakami, Yoshitaka ;
Saitoh, Shigeyuki ;
Okayama, Akira ;
Iso, Hiroyasu ;
Irie, Fujiko ;
Sairenchi, Toshimi ;
Miyamoto, Yoshihiro ;
Yamada, Michiko ;
Ishikawa, Shizukiyo ;
Miura, Katsuyuki ;
Ueshima, Hirotsugu ;
Okamura, Tomonori .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2017, 32 (07) :547-557
[25]   INCREASED HIGH-DENSITY-LIPOPROTEIN LEVELS CAUSED BY A COMMON CHOLESTERYL-ESTER TRANSFER PROTEIN GENE MUTATION [J].
INAZU, A ;
BROWN, ML ;
HESLER, CB ;
AGELLON, LB ;
KOIZUMI, J ;
TAKATA, K ;
MARUHAMA, Y ;
MABUCHI, H ;
TALL, AR .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (18) :1234-1238
[26]   LARGE AND CHOLESTERYL ESTER-RICH HIGH-DENSITY-LIPOPROTEINS IN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) DEFICIENCY CAN NOT PROTECT MACROPHAGES FROM CHOLESTEROL ACCUMULATION INDUCED BY ACETYLATED LOW-DENSITY LIPOPROTEINS [J].
ISHIGAMI, M ;
YAMASHITA, S ;
SAKAI, N ;
ARAI, T ;
HIRANO, K ;
HIRAOKA, H ;
KAMEDATAKEMURA, K ;
MATSUZAWA, Y .
JOURNAL OF BIOCHEMISTRY, 1994, 116 (02) :257-262
[27]   Relationship between serum triglyceride levels and endothelial function in a large community-based study [J].
Kajikawa, Masato ;
Maruhashi, Tatsuya ;
Matsumoto, Takeshi ;
Iwamoto, Yumiko ;
Iwamoto, Akimichi ;
Oda, Nozomu ;
Kishimoto, Shinji ;
Matsui, Shogo ;
Aibara, Yoshiki ;
Hidaka, Takayuki ;
Kihara, Yasuki ;
Chayama, Kazuaki ;
Goto, Chikara ;
Noma, Kensuke ;
Nakashima, Ayumu ;
Tomiyama, Hirofumi ;
Takase, Bonpei ;
Yamashina, Akira ;
Higashi, Yukihito .
ATHEROSCLEROSIS, 2016, 249 :70-75
[28]   DEFICIENCY OF SERUM CHOLESTERYL-ESTER TRANSFER ACTIVITY IN PATIENTS WITH FAMILIAL HYPERALPHALIPOPROTEINEMIA [J].
KOIZUMI, J ;
MABUCHI, H ;
YOSHIMURA, A ;
MICHISHITA, I ;
TAKEDA, M ;
ITOH, H ;
SAKAI, Y ;
SAKAI, T ;
UEDA, K ;
TAKEDA, R .
ATHEROSCLEROSIS, 1985, 58 (1-3) :175-186
[29]   Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease [J].
Lincoff, A. Michael ;
Nicholls, Stephen J. ;
Riesmeyer, Jeffrey S. ;
Barter, Philip J. ;
Brewer, H. Bryan ;
Fox, Keith A. A. ;
Gibson, C. Michael ;
Granger, Christopher ;
Menon, Venu ;
Montalescot, Gilles ;
Rader, Daniel ;
Tall, Alan R. ;
McErlean, Ellen ;
Wolski, Kathy ;
Ruotolo, Giacomo ;
Vangerow, Burkhard ;
Weerakkody, Govinda ;
Goodman, Shaun G. ;
Conde, Diego ;
McGuire, Darren K. ;
Nicolau, Jose C. ;
Leiva-Pons, Jose L. ;
Pesant, Yves ;
Li, Weimin ;
Kandath, David ;
Kouz, Simon ;
Tahirkheli, Naeem ;
Mason, Denise ;
Nissen, Steven E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (20) :1933-1942
[30]   Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial [J].
Luescher, Thomas F. ;
Taddei, Stefano ;
Kaski, Juan-Carlos ;
Jukema, J. Wouter ;
Kallend, David ;
Munzel, Thomas ;
Kastelein, John J. P. ;
Deanfield, John E. .
EUROPEAN HEART JOURNAL, 2012, 33 (07) :857-+